Scaling DNA & Large RNA Construct Production, Analytics & Quality Control for cGMP Compliant Vaccines, Therapeutics & RNA-Based Cell & Gene Therapies
As the mRNA field evolves beyond vaccines into diverse modalities, delivery systems, and therapeutic areas, mastering evolving CMC and process requirements is more important than ever. With regulatory scrutiny on CMC packages and new draft guidelines emerging from the EMA, the call for robust, high quality, quick and cost effective methods is monumental.
mRNA pipelines are maturing, but complexity continues to grow - from dsRNA impurities and manufacturing automation to scaling for GMP readiness and stability. As the field faces increasing regulatory expectations and new modalities like circular and self-amplifying RNA enter the clinic, the industry must redefine what process excellence looks like.
The 4th mRNA Process Development & CMC Summit will unite the Process, CMC, Manufacturing and Regulatory leaders driving this transformation to build a new standard for mRNA production and compliance.
The event provided a great opportunity to meet and discuss mRNA process development and share experiences and generate data to fill in knowledge gaps that will help with understanding the technology platform.
Michael Anyadiegwu, CMC Innovations & Technology Lead, CEPI
The event provided a great opportunity to meet and discuss mRNA process development and share experiences and generate data to fill in knowledge gaps that will help with understanding the technology platform.
Markus Bergmann, Global Head of Personalised Cancer Vaccines, CureVac
I appreciated the opportunity to engage with experts globally. The collaborative atmosphere and the openness of participants to share challenges and solutions created a dynamic and inspiring environment.
Rita Correro, Chief Technology Office, Inofea AG
Join Your Peers To:
This is your opportunity to join Europe’s most comprehensive, end-to-end forum, exclusively dedicated to mRNA Process Development and CMC - where science, regulation, and collaboration come together to define the next chapter of process excellence in mRNA therapeutics and vaccines and bring safer mRNA drugs to patients.
Explore the Full Event Guide
- Exclusive, Brand New Workshops
- 12+ Case Studies on Novel mRNA Production Strategies
- Unrivalled Networking Opportunities
- 22+ World Class Expert Speakers
- Europe’s ONLY End-to-End Forum Exclusively Focused on Process Development & CMC
Official Partners
Attending Companies Include
Explore Related Events
Explore the Agenda
Dive into cutting-edge mRNA Process Development & CMC strategies that will become your blueprint to high quality, safe and cost-effective mRNA production.
Partner With Us
Showcase your technologies and services to decision-makers actively seeking and driving next-generation mRNA therapeutics and vaccines.
Join mRNA Leaders
Be part of the only forum uniting leading pharma, biotech, academia and regulatory experts.